Pruritus Therapeutic Global Market Report 2024

Description

“Pruritus Therapeutic Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pruritus therapeutic market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressant; Calcineurin Inhibitors; Others Types
2) By Disease Type: Atopic Dermatitis Or Eczema; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
3) By Application: External Use; Oral; Injection
4) By End Use: Hospitals; Clinics; Other Uses
Companies Mentioned: Allergan plc; Astellas Pharma Inc.; Bristol-Myers Squibb Company; Cipla Inc.; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pruritus therapeutic refers to the treatment of pruritus, an uncomfortable sensation that prompts a person to scratch. Pruritus can be caused by various factors, including contact with allergens, dry skin, pregnancy, and reactions to medications.

The main types of pruritus therapeutic treatments include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids are a type of anti-inflammatory medication that closely resembles the hormone cortisol naturally produced by the adrenal glands. Pruritus can manifest in different diseases such as atopic dermatitis or eczema, allergic contact dermatitis, urticaria, cutaneous T-cell lymphoma, and others. Treatment methods include external use through application, oral administration, and injection. These therapies are commonly employed by hospitals, clinics, and other medical facilities.

The pruritus therapeutic market research report is one of a series of new reports from The Business Research Company that provides pruritus therapeutic market statistics, including pruritus therapeutic industry global market size, regional shares, competitors with a pruritus therapeutic market share, detailed pruritus therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutic industry. This pruritus therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutic market size has grown strongly in recent years. It will grow from $13.1 billion in 2023 to $14.2 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of pruritus, advancements in research and development, a growing aging population, the expansion of healthcare infrastructure, increasing awareness among patients, and collaborations and partnerships within the healthcare sector.

The pruritus therapeutic market size is expected to see strong growth in the next few years. It will grow to $19.1 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth in the forecast period can be attributed to factors such as continued research and innovation in pruritus therapeutic approaches, the growth of emerging markets, increased healthcare expenditure, the trend towards personalized medicine, and regulatory support for innovation in the healthcare sector. Major trends expected in the forecast period include the integration of telemedicine and digital health solutions, advancements in technology, the adoption of telehealth services, a focus on the global regulatory landscape, the development of biologics and immunomodulators, and patient-centric approaches to healthcare.

The growth of pruritus therapeutics is significantly fueled by the increasing incidences of skin disorders. Dermatologic conditions, such as acne, eczema, skin cancer, psoriasis, and vitiligo, collectively referred to as skin disorders, are on the rise. Pruritus therapeutics play a crucial role in treating various skin diseases, as pruritus is a predominant symptom in most cases. For instance, melanoma, as reported by the American Academy of Dermatology Association in April 2022, is expected to result in 7,650 deaths in 2022. Moreover, the American Cancer Society projects 97,610 new melanoma cases to be diagnosed in the United States in 2023. This increase in skin disorders underscores the driving force behind the growth of the pruritus therapeutic market.

The growth of the pruritus therapeutic market is expected to be propelled by the increasing incidence of chronic kidney disease. Chronic Kidney Disease (CKD), characterized by a gradual decline in kidney function, is linked to pruritus, commonly known as itching. The Australian Institute of Health and Welfare reported in June 2023 that CKD was responsible for around 20,000 deaths in Australia in 2021, contributing to 12% of all deaths. Furthermore, the number of CKD-related deaths has increased by 97% over the past two decades. The connection between pruritus and CKD establishes a significant driver for the pruritus therapeutic market.

Product innovation emerges as a prominent trend in the pruritus therapeutic market, with major companies focusing on the development of innovative medications and treatments for pruritus and related conditions. An example is Maruho Co., Ltd., a Japan-based pharmaceutical company, which introduced the anti-IL-31 receptor, a humanized monoclonal antibody named Mitchga Subcutaneous Injection. Launched in August 2022, it serves as a treatment for itching associated with atopic dermatitis, inhibiting IL-31 signaling and addressing pruritus and skin inflammation.

Major companies in the pruritus therapeutic market are adopting a strategic partnership approach to address moderate-to-severe atopic dermatitis. This collaborative strategy involves leveraging each other's strengths and resources for mutual benefits. Amgen Inc., a US-based biopharmaceutical company, partnered with Kyowa Kirin to investigate rocatinlimab, a potential anti-OX40 monoclonal antibody for moderate to severe atopic dermatitis. The Phase 3 trial, known as ROCKET, is a global initiative aimed at studying the safety and effectiveness of rocatinlimab. This strategic partnership underscores the collaborative efforts in advancing therapeutic solutions.

In March 2023, Ipsen, a France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based biopharmaceutical company. This strategic acquisition adds promising therapies for uncommon cholestatic liver disorders, novel pipeline prospects, and technical and financial strength to Ipsen's portfolio. Albireo Pharma, Inc. specializes in developing and commercializing novel bile acid modulators for the treatment of orphan pediatric liver diseases, gastrointestinal disorders, and pruritus-related conditions in drug development.

Major companies operating in the pruritus therapeutic market report are Allergan plc, Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Actavis plc, Albireo Pharma Inc., Amgen Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Evelo Bioscience Inc., Huapont Life Sciences Co. Ltd., J&J Services Inc., LEO Pharma AS, MC2 Therapeutics Ltd., Mylan NV, Novan Inc., Ocera Therapeutics Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd

North America was the largest region in the pruritus therapeutic market in 2023. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pruritus therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutic market includes revenues earned by entities by treating pruritus conditions with medicines such as aloe vera, menthol and petroleum jelly. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11273

1. Executive Summary

2. Pruritus Therapeutic Market Characteristics

3. Pruritus Therapeutic Market Trends And Strategies

4. Pruritus Therapeutic Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Pruritus Therapeutic Market Size and Growth

5.1. Global Pruritus Therapeutic Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pruritus Therapeutic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pruritus Therapeutic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pruritus Therapeutic Market Segmentation

6.1. Global Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others Types
6.2. Global Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Atopic Dermatitis Or Eczema
Allergic Contact Dermatitis
Urticaria
Cutaneous T-Cell
Other Disease Types
6.3. Global Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
External Use
Oral
Injection
6.4. Global Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other Uses

7. Pruritus Therapeutic Market Regional And Country Analysis

7.1. Global Pruritus Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pruritus Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pruritus Therapeutic Market

8.1. Asia-Pacific Pruritus Therapeutic Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pruritus Therapeutic Market

9.1. China Pruritus Therapeutic Market Overview
9.2. China Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pruritus Therapeutic Market

10.1. India Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pruritus Therapeutic Market

11.1. Japan Pruritus Therapeutic Market Overview
11.2. Japan Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pruritus Therapeutic Market

12.1. Australia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pruritus Therapeutic Market

13.1. Indonesia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pruritus Therapeutic Market

14.1. South Korea Pruritus Therapeutic Market Overview
14.2. South Korea Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pruritus Therapeutic Market

15.1. Western Europe Pruritus Therapeutic Market Overview
15.2. Western Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pruritus Therapeutic Market

16.1. UK Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pruritus Therapeutic Market

17.1. Germany Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pruritus Therapeutic Market

18.1. France Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pruritus Therapeutic Market

19.1. Italy Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pruritus Therapeutic Market

20.1. Spain Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pruritus Therapeutic Market

21.1. Eastern Europe Pruritus Therapeutic Market Overview
21.2. Eastern Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pruritus Therapeutic Market

22.1. Russia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pruritus Therapeutic Market

23.1. North America Pruritus Therapeutic Market Overview
23.2. North America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pruritus Therapeutic Market

24.1. USA Pruritus Therapeutic Market Overview
24.2. USA Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pruritus Therapeutic Market

25.1. Canada Pruritus Therapeutic Market Overview
25.2. Canada Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pruritus Therapeutic Market

26.1. South America Pruritus Therapeutic Market Overview
26.2. South America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pruritus Therapeutic Market

27.1. Brazil Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pruritus Therapeutic Market

28.1. Middle East Pruritus Therapeutic Market Overview
28.2. Middle East Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pruritus Therapeutic Market

29.1. Africa Pruritus Therapeutic Market Overview
29.2. Africa Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pruritus Therapeutic Market Competitive Landscape And Company Profiles

30.1. Pruritus Therapeutic Market Competitive Landscape
30.2. Pruritus Therapeutic Market Company Profiles
- 30.2.1. Allergan plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Astellas Pharma Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bristol-Myers Squibb Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Cipla Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eli Lilly and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Pruritus Therapeutic Market Competitive Benchmarking

32. Global Pruritus Therapeutic Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pruritus Therapeutic Market

34. Pruritus Therapeutic Market Future Outlook and Potential Analysis

34.1 Pruritus Therapeutic Market In 2028 - Countries Offering Most New Opportunities
34.2 Pruritus Therapeutic Market In 2028 - Segments Offering Most New Opportunities
34.3 Pruritus Therapeutic Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer